Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,092,230
+$1,512,906 QoQ
Shares Held
5,913
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#1,460
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. LLY ranks #3 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
|
9,550 | $229,964 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,092,230 | 5,913 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,579,324 | 6,066 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,919,865 | 6,439 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,017,488 | 6,576 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,007,563 | 5,141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,050,085 | 3,693 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,960,108 | 2,539 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,326,478 | 2,626 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,320,488 | 2,563 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,788,530 | 2,299 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,259,690 | 2,161 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,316,505 | 2,451 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,085,219 | 2,314 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $742,474 | 2,162 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $778,873 | 2,129 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $680,328 | 2,104 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $719,466 | 2,219 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $672,683 | 2,349 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $648,840 | 2,349 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $561,220 | 2,429 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $557,504 | 2,429 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $457,522 | 2,449 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $388,163 | 2,299 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $340,297 | 2,299 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $344,613 | 2,099 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $223,894 | 1,614 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||